| Application no. and date | 13864403.4 (espacenet) (Federated) (European Patent Register), 20131219 | | Patent/reg. no. and date | DK/EP 2935303, 20210217 | | Publication date | 20151028 | | Priority no. and date | US 201261745466 P, 20121221, US 201361890125 P, 20131011 | | EP pub. no. and date |
EP 2935303 20151028 | | Effective date | | | Applicant/owner | Janssen BioPharma, Inc., 260 E. Grand Ave., 2nd Floor
South San Francisco, CA 94080, US | | Applicant ref. no. | 1584684 | | Inventor | WANG, Guangyi, 5066 Millay Court
Carlsbad, CA 92008, US,
BEIGELMAN, Leonid, 991 East Grant Place
San Mateo, CA 94402, US,
SMITH, David, Bernard, 218 W. 40th Avenue
San Mateo, CA 94403, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/7068 (2006.01) , A61K 31/7072 (2006.01) , A61K 31/7076 (2006.01) , A61K 31/708 (2006.01) , A61P 31/14 (2006.01) , C07H 19/067 (2006.01) , C07H 19/073 (2006.01) , C07H 19/10 (2006.01) , C07H 19/167 (2006.01) , C07H 19/173 (2006.01) , C07H 19/20 (2006.01) , C07H 19/213 (2006.01) | | Title | 4`-fluornukleosider, 4`-fluornukleotider og analoger dertil til behandling af HCV | | Int. application no. | US2013076740 | | Int. publication no. | WO2014100505 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
